Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ADC189 tablets/granules for post-exposure prevention of influenza in adults and children
CTR20260138Phase 3Active
- Sponsor
- Jiaxing AnDiCon Biotech
- Start
- Jan 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of deunoxavir marboxil in Influenza A infection, influenza B, sponsored by Jiaxing AnDiCon Biotech. Started Jan 2026; status: active.
02
Drugs
deunoxavir marboxil
03
Conditions
Influenza A infectioninfluenza B
Beyond the preview
Go deeper on CTR20260138.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20260138.